Articles

Results 1 to 5 of 24
Most popular |Most recent


A general introduction to pharmaceutical IP and competition issues in United Kingdom

United Kingdom - September 30 2021 This article examines the most consequential features of the IP and competition law frameworks in relation to the pharmaceutical sector in United Kingdom, with particular regard to recent developments.

Pieter Erasmus, Bróna Heenan, Chris de Mauny, Peter Willis.

Spotlight: competition law in the pharmaceutical sector in United Kingdom

United Kingdom - September 30 2021 This article reviews the application of competition law principles to the pharmaceutical sector in United Kingdom, with particular regard to the merger control regime and anticompetitive behaviour.

Pieter Erasmus, Bróna Heenan, Chris de Mauny, Peter Willis.

London & the life sciences

European Union, United Kingdom - April 29 2021 Europe’s biotech industry is more buoyant now than it’s ever been. A combination of eager investors, the high-speed development of COVID-19 vaccines…

James Baillieu, Toby Bond.

London & Brexit

European Union, United Kingdom - March 11 2021 For those living and working in London, the last year has been one like no other. On the 31st of January 2020, the UK departed the…

Yuichi Sekine.

A general introduction to pharmaceutical IP and competition issues in United Kingdom

United Kingdom - October 6 2020 This article examines the most consequential features of the IP and competition law frameworks in relation to the pharmaceutical sector in United Kingdom, with particular regard to recent developments.

Pieter Erasmus, Bróna Heenan.